CORRECTING and REPLACING Bristol Myers Squibb Announces Opdivo plus Chemotherapy and Opdivo plus Yervoy Demonstrate Superior Survival Benefit Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal... Biotech Investing
Abbott Receives CE Mark Approval for Next-Generation TriClip Device, Offering New Innovations for Tricuspid Heart Valve Repair Medical Device Investing
Portage Biotech Highlights First Patient Dosed in PRECIOUS-01 Study of PORT-3 for the Treatment of NY-ESO-1 Positive Solid Tumors Biotech Investing
Aptose to Present at Canaccord Genuity 2021 Horizons in Oncology Virtual Conference Biotech Investing
Bristol Myers Squibb Announces Opdivo plus Chemotherapy and Opdivo plus Yervoy Demonstrate Superior Survival Benefit Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma Biotech Investing
Merck's KEYTRUDA® Demonstrated Superior Disease-Free Survival Compared With Placebo as Adjuvant Therapy in Patients With Renal Cell Carcinoma Following Surgery Pharmaceutical Investing
Aurinia Presents Data Demonstrating LUPKYNIS Efficacy Across Lupus Nephritis Biopsy Classes at National Kidney Foundation 2021 Spring Clinical Meetings Biotech Investing
FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival Biotech Investing
